Headquarters
324 BLACKWELL ST STE 900, DURHAM, NC 27701-3659, US
DURHAM, NC, US
EYDIS BIO, INC.
From the company
EydisBio is a small biotech startup based in Durham, NC focused on the development of highly selective and potent novel small molecule kinase inhibitors. Its current TAK1 program is described as the first to develop a highly selective, orally bioavailable inhibitor of TAK1 for the treatment of inflammatory-mediated diseases such as RA, systemic sclerosis, chronic pain, viral-induced ARDS, and SLE. The company uses its Universal Purinome Capture Platform (UPCP) chemoproteomics platform to identify protein kinases of interest.
Products & services offered
Facilities
Send your requirements
Quantities, certifications, and timing.